1994/10/01 by Steen Pehrson, Carina Blomströ‐LUNDQVIST, Erik Ljungströ +1 · 1 citation
Medicine · #Cardiac Arrhythmias and Treatments #Atrial Fibrillation Management and Outcomes #Cardiac pacing and defibrillation studies #Medicine #Palpitations #Supraventricular tachycardia #Internal medicine #Cardiology #Tachycardia #Atrial fibrillation #Electrocardiography #Paroxysmal supraventricular tachycardia #Atrial tachycardia #Anesthesia #Atropine #Catheter ablation
paper · pdf · doi:10.1002/clc.4960171004
openalex publication_date 1994/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/23
The main objective of the present study was to evaluate the clinical applicability of transesophageal atrial stimulation (TAS) and recording with regard to inducibility of supraventricular tachycardia (SVT) in patients with either an ECG-documented paroxysmal SVT or a clinical history of palpitations suggesting this disease. A further objective was to assess the inducibility of SVT and to compare the inducibility by TAS with that obtained by an invasive electrophysiologic study (EPS). A total of 64 patients (aged 13-74 years) with ECG-documented paroxysmal SVT (n = 50) or only a history of palpitations (n = 14) was referred for TAS. Preexcitation was present in 35 patients. The study protocol included single and double extrastimuli delivered at a basic paced interval of 500 ms, and incremental atrial stimulation until a cycle length of 275 ms or a second-degree AV block appeared. In 10 patients atropine intravenously was required for induction. The same protocol was used in 34 of the patients who also underwent invasive EPS. TAS was completed in 56 of 64 patients (88%). In this group SVT was induced during TAS in 84% (47/56). Of patients with ECG-documented tachycardia, clinical tachycardia was induced in 90% (35/39) with ECG-documented regular paroxysmal SVT and in 67% of patients (4/6) with ECG-documented atrial fibrillation. In patients without ECG-documented atrial fibrillation. In patients without ECG-documented tachycardia, clinically relevant arrhythmia was induced in 73% (8/11). In 30 of 32 patients (94%) with an inducible tachycardia during invasive EPS, it was also possible to induce the tachycardia by TAS.(ABSTRACT TRUNCATED AT 250 WORDS)